HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Quantitative analysis on in vitro drug sensitivity of cultured human ovarian cancer cell lines (author's transl)].

Abstract
Two cell lines, Kuramochi and CKS, established from human ovarian cancer, were analyzed in vitro drug sensitivity to Mitomycin C and Carboquone. These values were compared to those of eight human gastric cancer cell lines composed of various histological types. The CKS cell line, derived from serious cystadenocarcinoma, was less sensitive to both test-drugs than the groups of gastric cancer cell lines. Therapeutic indices of the two drugs were very low. So it was considered that the two drugs were unsuitable to chemotherapy to serous cystadenocarcinoma. The Kuramochi cell line, derived from undifferentiated carcinoma, was less sensitive to Mitomycin C than the groups of gastric cancer cell line. However, it was as sensitive to Carboquone as high-sensitive gastric cancer cell lines. Therapeutic index of the Carboquone in the undifferentiated carcinoma was high. So it was considered that Carboquone was suitable to chemotherapy to undifferentiated adenocarcinoma. The cytocydal actions of the two drugs were dependent upon dose and time. Time-dependency was, however, smaller in Carboquone than in Mitomycin C.
AuthorsT Motoyama
JournalNihon Sanka Fujinka Gakkai zasshi (Nihon Sanka Fujinka Gakkai Zasshi) Vol. 34 Issue 3 Pg. 308-14 (Mar 1982) ISSN: 0300-9165 [Print] Japan
PMID7069245 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Azirines
  • Mitomycins
  • Carbazilquinone
Topics
  • Azirines (pharmacology)
  • Carbazilquinone (pharmacology)
  • Carcinoma (pathology)
  • Cell Line
  • Cell Survival (drug effects)
  • Cystadenocarcinoma (pathology)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • In Vitro Techniques
  • Mitomycins (pharmacology)
  • Ovarian Neoplasms (pathology)
  • Stomach Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: